2014 Spring ADRC Meeting

Note: Following are links to available presentations from the meeting. The full agendas can be found here.

Administrators Meeting

Welcome and opening remarks
Dana Swenson-Dravis, MA; Chair, ADRC Administrators Steering Committee, Administrator, Mayo Clinic
Program income, price-setting, and cost recovery for biospecimen sharing
Virginia Buckles, PhD; Administrator, Washington University in St. Louis
ASSISTed living
Mary Sundsmo, MBA; Administrator, University of California, San Diego
Kathy Jedrziewski, PhD; Administrator, University of Pennsylvania
Clinical Trials in the Era of Prevention — Scientific symposium
Randall Bateman, MD
Director, Dominantly Inherited Alzheimer's Network Therapeutic Trials Unit (DIAN IU)
Jessica Langbaum, PhD
Associate Director, Alzheimer's Prevention Initiative (API)
Reisa Sperling, MD, MMSc — Project Leader, Anti-Amyloid Treatment in Asymptomatic AD — The "A4" Trial
Suzanne Craft, PhD — Project Leader, Study of Nasal Insulin to Fight Forgetfulness (SNIFF)

Directors Meeting

NIA update
Richard Hodes, MD; Director, NIA
NIA update
Neil S. Buckholtz, PhD; Director, Division of Neuroscience, NIA
NACC update
Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
ADGC update
Gerard Schellenberg, PhD; PI, Alzheimer's Disease Genetics Consortium
NCRAD update
Tatiana Foroud, PhD; PI, National Cell Repository for Alzheimer's Disease
NIAGADS update
Li-San Wang, PhD; PI, NIA Genetics of Alzheimer's Disease Data Storage Site
Clinical Task Force update
John C. Morris, MD; Chair, ADRC Clinical Task Force
National Alzheimer's Project Act (NAPA) update
Ronald C. Petersen, PhD, MD; Director, Mayo Clinic
Update on the revision to "NIA Biospecimen Best Practices Guidelines for the ADRCs"
Thomas J. Montine, MD, PhD; Director, University of Washington
BrainHealthRegistry.org — an internet-based portal for recruitment, assessment, screening, and longitudinal monitoring of subjects for clinical observationa or treatment trials
Michael W. Weiner, MD; PI, Alzheimer's Disease Neuroimaging Initiative
Junior Investigator Symposium — Introduction
Linda Van Eldik, PhD; Chair, ADRC Executive Committee
Early changes in the brain proteome associated with Alzheimer's disease risk
Nick Seyfried, PhD; Emory University
Integrating brain imaging and genetics to uncover risk for Alzheimer's disease
Robyn Honea, DPhil; University of Kansas

Clinical Core Leaders Meeting

UDS 3.0 update — review of protocol with changes from 12/13 teleconferences, and design of the crosswalk study
Sandra Weintraub, PhD; Clinical Core Leader, Northwestern University
UDS 3.0 crosswalk preliminary findings/results
Sarah Monsell, MS; Research Scientist, National Alzheimer's Coordinating Center
NACC imaging initiative update
Charles DeCarli, MD; Director, University of California, Davis
AD Lumbar Puncture Survey preliminary results
Krista Moulder, PhD; Associate Executive Director, Washington University in St. Louis

If you’re unable to find what you’re looking for, please don’t hesitate to contact us.

4311 – 11th Avenue NE, Suite 300, Seattle, WA 98105 |(206) 543-8637 | NACCmail@uw.edu

  • |
  • |
  • |

NACC is funded by the National Institute on Aging (U24 AG072122) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. © 2022 University of Washington